MIR Earnings Prediction
The chart below shows how MIR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MIR sees a -2.76% change in stock price 10 days leading up to the earnings, and a -1.31% change 10 days following the report. On the earnings day itself, the stock moves by -1.36%. This data can give you a slight idea of what to expect for the next quarter's release.
MIR Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
206.80M
8.16%
-0.14%
Gross Margin
44.92%
6.29%
-4.49%
Operating Margin
-0.63%
-88.95%
-126.58%
Net Margin
-6.77%
0.30%
16.93%
EPS
-0.07
-16.67%
16.67%
No Data Available
MIR Earnings Analysis
Mirion Technologies, Inc. Corporation (MIR.N) Earnings Conference Call
Positive
Third Quarter Revenue Increase: $207 million of third quarter revenue was 8% higher compared to last year's third quarter.
Adjusted EPS Performance: Adjusted EPS was $0.08 per share.
EBITDA Margin Improvement: Adjusted EBITDA was $45.7 million with 180 basis points of margin improvement compared to the year ago period.
EBITDA Margin Improvement: The Q3 Medical EBITDA margin is up 50 basis points to 34.7% versus 2023 and the Technologies EBITDA margin is up 370 basis points for the same period.
Quarterly Revenue Increase: Third quarter revenue grew 8.2% versus the prior year to $206.8 million.
Negative
Third Quarter Revenue Increase: Third quarter revenue was $207 million, which was 8% higher compared to last year's third quarter, indicating a slower growth rate than expected.
Decline in Adjusted EPS: Adjusted EPS was $0.08 per share, reflecting a decline in profitability compared to previous quarters.
Adjusted EBITDA Performance: Adjusted EBITDA was $45.7 million with a margin improvement of only 180 basis points compared to the year-ago period, suggesting limited operational efficiency gains.
Order Rate Decline: The third quarter order rate declined approximately 30% versus prior year's third quarter, indicating a significant drop in demand.
Backlog Growth vs. Order Decline: The backlog was $815 million or 2% higher versus the same quarter last year, but this growth is not sufficient to offset the declining order rate.
MIR FAQs
How does MIR typically perform around its earnings report dates?
Is Mirion Technologies, Inc. (MIR) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MIR Earning Call Sentiment
Mirion Technologies, Inc. (MIR) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MIR.N
-0.46%Positive
The earnings call summary presents a generally positive outlook with an 8% YoY revenue increase, improved EBITDA margins, and strategic partnerships like the one with EDF. Despite some challenges like order volatility and supply chain issues in China, the company has raised its financial guidance and expects significant growth in nuclear medicine. The Q&A section revealed management's optimism about future opportunities, particularly in radiopharmaceutical therapies and strategic alliances. Given the company's market cap, these factors suggest a positive stock price movement of 2% to 8% over the next two weeks.
